Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
New MASAC Recommendation on Prophylaxis Available on NHF Web Site
 

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) issued a new prophylaxis recommendation on November 3, 2007. It was adopted by NHF’s Board of Directors on November 4, 2007.

MASAC Document #179: MASAC Recommendation Concerning Prophylaxis

This document recognizes the proven benefits to patients with hemophilia of regularly administrating clotting factor to prevent bleeding. It lays out guidelines for prophylactic factor dosing, as well as recommendations supporting regular follow-up evaluations. It also stresses the need for patients to document bleeds and/or other complications. An appendix lists important considerations that patients and their families need to make prior to deciding on prophylaxis.

To request a copy of this MASAC recommendation, please contact HANDI, NHF’s information resource center, at 1.800.42.HANDI or handi@hemophilia.org. A complete list of current MASAC recommendations can also be accessed on the NHF Web site.

 

This section of our Web site is sponsored by: